Reactive oxygen and nitrogen species in inflammatory process;Znaczenie reaktywnych form tlenu i azotu w patomechanizmie procesu zapalnego

Polski Merkuriusz Lekarski

Volumn 23, Issue 134, 2007, Pages 131-136

  Rutkowski, Ryszard ^a   Pancewicz, Slawomir A ^b   Rutkowski, Krzysztof ^c   Rutkowska, Joanna ^d  

^a Laboratory of Respiratory Diagnostics and Bronchoscopy

^b Department of Infectious Diseases and Neuroinfections ^*

^c Queen Mary's Sidcup NHS Trust   (United Kingdom)

^d Nursing and Environment Protection Division

Author keywords

Oxidative stress; Pathological changes; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL; HUMAN; INFLAMMATION; METABOLISM; NEOPLASM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW;

ANIMALS; ANTIOXIDANTS; HUMANS; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INFLAMMATION; NEOPLASMS; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 34548575325     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Alderton W.K., Cooper C.E., Knowles R.G.: Nitric oxide syntheses: structure, function and inhibition. Biochem. J., 2001, 357, Pt 3, 593-615.
2. Andreadis A.A., Hazen S.L., Comhair S.A. i wsp.: Oxidative and nitrosative events in asthma, Free Radie. Biol. Med., 2003, 35, 213-225.
3. Augustyniak A., Skrzydlewska E.: Zdolności antyoksydacyjne w starzejacym sie organizmie. Post. Hig. Med. Dośw., 2004, 58, 184-201.
4. Barnham K.J., Masters C.L., Bush A.I.: Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov., 2004, 3, 205-214.
5. Behl C.: Alzheimer's disease and oxidative stress: implication for novel therapeutic approaches. Prog. Neurobiol., 1999, 57, 301-323.
6. Bergendi L., Benes L., Durackova Z. i wsp.: Chemistry, physiology and pathology of free radicals. Life Sci., 1999, 65, 1865-1874.
7. Bogdan Ch., Röllinghoff M., Diefenbach A.: Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol., 2000, 12, 64-76.
8. Bove P.F., van der Vliet A.: Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic. Biol. Med., 2006, 41, 515-527.
9. Crimi E., Sica V., Williams-Ignarro S. i wsp.: The role of oxidative stress in adult critical cares. Free Radic. Biol. Med., 2006, 40, 398-406.
10. Cuzzocrea S., Riley D.P., Caputi A.P. i wsp.: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev., 2001, 53, 135-159.
11. Dahlgren C., Karlsson A.: Respiratory burst in human neutrophils. J. Immunol. Meth., 1999, 232, 3-14.
12. Dröge W.: Free radicals in the physiological control of cell function. Physiol. Rev., 2002, 82, 47-95.
13. Evans J.L., Goldfine I.D., Maddux B.A. i wsp.: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev., 2002, 23, 599-622.
14. Hampton M.B., Kettle A.J., Winterbourn Ch.C.: Inside the neutrophil phagosome: oxidants, myeloperoxidase and bacterial killing. Blood, 1998, 92, 3007-30017.
15. Hamuro J., Murata Y., Suzuki M. i wsp.: The triggering and healing of tumor stromal inflammatory reactions regulated by oxidative and reductive macrophages. Cancer Res., 1999, 48, 153-164.
16. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med., 1995, 182, 751-758.
17. Jaruga P.: Mechanizmy oksydacyjne i antyoksydacyjne u nosicieli HIV-wpływ na progresje choroby. Post. Hig. Med. Dośw., 1999, 53, 43-54.
18. Kehrer J.P.: Free radicals as mediators of tissue injury and disease. Crit, Rev, Toxicol., 1993, 23, 21-48.
19. Kerr M.E., Bender C.M., Monti E.J.: An introduction to oxygen free radicals. Heart Lung, 1996, 25, 200-209.
20. Kirkham P., Rahman I.: Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol. Then, 2006, 111, 476-494.
21. Komosińska K., Olczyk K., Winsz K.: Rola wolnych rodników w etiopatogenezie twardziny układowej. Post. Hig. Med. Dośw., 1997, 51, 285-303.
22. Labro M.T.: Interference of antibacterial agents with phagocyte functions: immunomodulation or "Immuno-Fairy tales"? Clin. Microbiol. Rev., 2000, 13, 615-650.
23. Lirk P., Hoffmann G., Rieder J.: Inducible nitric oxide synthase - time for reappraisal. Curr. Drug Targets Inflamm. Allergy, 2002, 1, 89-108.
24. Lloyd-Jones D.M., Bloch K.D.: The vascular biology of nitric oxide and its role in atherogenesis. Ann. Rev. Med., 1996, 47, 365-375.
25. Loguercio C., Federico A.: Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med., 2003, 34, 1-10.
26. Los M., Dröge W., Stricker K. i wsp.: Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol., 1995, 25, 159-165.
27. Los M., Schenk H., Hexel K. i wsp.: IL-2 gene expression and NF-κB; activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J., 1995, 14, 3731-3740.
28. MacMicking J., Xie Q.W., Nathan C.: Nitric oxide and macrophage function. Ann. Rev. Immunol., 1997, 15, 323-350.
29. Naito Y., Yoshikawa T.: Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med, 2002, 33, 323-336.
30. Olinski R., Gackowski D., Foksinski M. i wsp.: Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic. Biol. Med., 2002, 33, 192-200.
31. Rahman I., Biswas S.K., Kode A.: Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol., 2006, 533, 222-239.
32. Ray G., Kumar V., Kapoor AV. i wsp.: Status of antioxidants and other biochemical abnormalities in children with Dengue fever. J. Trop. Pediatr., 1999, 45, 4-7.
33. Ricciardolo F.L, Di Stefano A., Sabatini F., Folkerts G.: Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol., 2006, 533, 240-252.
34. Salvemini D., Cuzzocrea S.: Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic. Biol. Med., 2002, 33, 1173-1185.
35. Schwarz K.B.: Oxidative stress during viral infection: a review. Free Radic. Biol. Med., 1996, 21, 641-649.
36. Skrzydlewska E., Farbiszewski R.: Interakcje wolnych rodników z białkami. Post. Hig. Med. Dośw., 1995, 49, 747-766.
37. Stocker R., Keaney J.F. Jr.: Role of oxidative modifications in atherosclerosis. Physiol. Rev., 2004, 84, 1381-1478.
38. Teixeira H.D., Schumacher R.I., Meneghini R.: Lower intracellular hydrogen peroxide levels in cells overexpressing CuZn-superoxide dismutase. Proc. Natl. Acad. Sci. USA., 1998, 95, 7872-7875.
39. Thannickal V.J., Fanburg B.L.: Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol., 2000, 279, L1005-L1028.
40. Valko M., Leibfritz D., Moncol J.I. wsp.: Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39, 44-84.
41. Vallance P., Leiper J.: Blocking NO synthesis: how, where and why? Nat. Rev. Drug Discov., 2002, 1, 939-950.
42. Wójcicka G., Bełtowski J., Jamroz A.: Stres oksydacyjny w nadciśnieniu tetniczym. Post. Hig. Med. Dośw., 2004, 58, 183-193.
43. Wu K.K., Thiagarajan P.: Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med., 1996, 47, 315-331.